Over 50% of participants on opioids for chronic pain from the OpSafe Trial with newly diagnosed sleep apnea declined attendance for sleep clinic review or treatment, and 25% completed specific sleep apnea–related treatment. Of those who pursued PAP therapy, adherence was similar to that in the general population at 1 year and was proven to be effective in abolishing the sleep apnea. Further studies are required to explore factors influencing this population’s lack of engagement with sleep health providers and barriers to adherence to PAP therapy.
Comentarios